DOCK3 regulates normal skeletal muscle regeneration and glucose metabolism
Adrienne SamaniiD, Muthukumar KaruppasamyiD, Katherine G. EnglishiD, Colin A. SileriD, Y. WangiD, Jeffrey J. WidrickiD, Matthew S. AlexanderiD
Abstract
DOCK (dedicator of cytokinesis) is an 11-member family of typical guanine nucleotide exchange factors (GEFs) expressed in the brain, spinal cord, and skeletal muscle. Several DOCK proteins have been implicated in maintaining several myogenic processes such as fusion. We previously identified DOCK3 as being strongly upregulated in Duchenne muscular dystrophy (DMD), specifically in the skeletal muscles of DMD patients and dystrophic mice. Dock3 ubiquitous KO mice on the dystrophin-deficient background exacerbated skeletal muscle and cardiac phenotypes. We generated Dock3 conditional skeletal muscle knockout mice (Dock3 mKO) to characterize the role of DOCK3 protein exclusively in the adult muscle lineage. Dock3 mKO mice presented with significant hyperglycemia and increased fat mass, indicating a metabolic role in the maintenance of skeletal muscle health. Dock3 mKO mice had impaired muscle architecture, reduced locomotor activity, impaired myofiber regeneration, and metabolic dysfunction. We identified a novel DOCK3 interaction with SORBS1 through the C-terminal domain of DOCK3 that may account for its metabolic dysregulation. Together, these findings demonstrate an essential role for DOCK3 in skeletal muscle independent of DOCK3 function in neuronal lineages.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 9
- FWCI
- 0.80
- Field percentile
- top 33%
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- DOCK3 is a dosage-sensitive regulator of skeletal muscle and Duchenne muscular dystrophy-associated pathologies.
Andrea L. Reid, Yimin Wang, … Matthew S. Alexander·Human Molecular GeneticsPeer-reviewed·Jul 31, 2020
- Galectin-3 and N-acetylglucosamine promote myogenesis and improve skeletal muscle function in the mdx model of Duchenne muscular dystrophy
A. Rancourt, S. Dufresne, … S. Sato·bioRxiv·Oct 16, 2017
- GSK3 inhibition improves skeletal muscle function and whole-body metabolism in the severe DBA/2J mdx mouse model
B. M. Marcella, B. Hockey, … V. Fajardo·bioRxiv·Feb 16, 2022
- The microRNA, miR-133b, functions to slow Duchenne muscular dystrophy pathogenesis
T. Taetzsch, D. Shapiro, … G. Valdez·bioRxiv·Mar 19, 2020
- Receptor-interacting protein kinase-3 mediates both myopathy and cardiomyopathy in preclinical animal models of Duchenne muscular dystrophy
- Electrophysiological analysis of healthy and dystrophic 3D bioengineered skeletal muscle tissues
C. T. Nguyen, M. Ebrahimi, … B. A. Stewart·bioRxiv·Nov 10, 2020